PerturbAI Partners with OpenAI and Scripps Research on AI Reasoning Framework

On October 21, biotechnology company PerturbAI announced a collaboration with OpenAI and Scripps Research to develop an AI reasoning framework. The framework will leverage thousands of agents to analyze biological experimental data in parallel, search scientific literature, and propose testable research hypotheses, aiming to accelerate biomedical research and explore new drug targets.

PerturbAI focuses on biotechnology, OpenAI is a key player in artificial intelligence, and Scripps Research is a long-established biomedical research institution. The partnership aims to bring large-scale AI reasoning capabilities into biomedical research workflows.